PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Public Health, College of Public Health and Health Informatics, University of Ha\'il, Ha\'il 2440, Saudi Arabia.\', \'Department of Histology and Cell Biology, Faculty of Medicine, Zagazig University, Zagazig 44519, Egypt.\', \'Department of Health Promotion and Behavioral Sciences, University of Texas Health Sciences at Houston, Houston, TX 77030, USA.\', \'Department of Management, Policy and Community Health, University of Texas Health Sciences at Houston, Houston, TX 77030, USA.\', \'Department of Internal Medicine, College of Medicine, University of Ha\'il, Ha\'il 2240, Saudi Arabia.\', \'Department of Internal Medicine, Faculty of Medicine, Zagazig University, Zagazig 44519, Egypt.\']
?:citedBy
  • -1
?:creator
?:doi
  • 84210.3390/medicina57080842
?:doi
?:hasPublicationType
?:journal
  • Medicina (Kaunas, Lithuania)
is ?:pmid of
?:pmid
?:pmid
  • 34441048
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.422
?:rankingScore_hIndex
  • 29
is ?:relation_isRelatedTo_publication of
?:title
  • The Prospect of Lactoferrin Use as Adjunctive Agent in Management of SARS-CoV-2 Patients: A Randomized Pilot Study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all